Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

Clinical trial NCT06005012 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06005012
Sponsor: University of California, San Diego
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Fibrosis, Liver Type 2 Diabetes Mellitus in Obese Non-Alcoholic Fatty Liver Disease

Start date: 2023-07-25
Primary completion: 2026-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.